ICBio vs PharPoint Research

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/icbiocro/pharpoint

Category	ICBio	PharPoint Research
Listed site	cro	cro
Summary	ICBio is a Bengaluru-based CRO offering bioavailability/bioequivalence studies, phase II–IV clinical trials, and LC-MS/MS bioanalysis. The excerpts cite regulatory approvals from DCGI-CDSCO, ANVISA, and EMA.	PharPoint is a US-based CRO specializing in Phase I–IV clinical trials with rapid biometrics timelines, delivering database locks within 5 days of last patient visit and topline results in 2 business days.
Services	Phase I Clinical Trials Phase II Clinical Trials Phase III Clinical Trials Phase IV / Post-Marketing Clinical Trial Services Clinical Operations Bioanalysis LC-MS Bioanalysis (Small Molecule) Biostatistics & Statistical Programming Data Management & eClinical Medical Writing Pharmacovigilance & Drug Safety Regulatory Affairs Central Laboratory Services	Phase I Clinical Trials Phase II Clinical Trials Phase III Clinical Trials Phase IV / Post-Marketing Clinical Operations Data Management & eClinical Biostatistics & Statistical Programming Medical Writing Regulatory Affairs
Modalities	Small Molecule	Data not yet provided.
Indications	Data not yet provided.	Data not yet provided.
Locations	Headquarters, Bengaluru, India	Data not yet provided.
Certifications	ISO · Identifier: ISO 9001:2015 ISO · Identifier: ISO 15189:2012 ISO · Identifier: ISO 14001:2015 ISO/IEC · Identifier: ISO/IEC 27001:2013 OHSAS · Identifier: OHSAS 18001:2007	Data not yet provided.
Reviews	Review summary appears after site-level review signal gate opens.	Review summary appears after site-level review signal gate opens.